Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)
ACHN.O on Nasdaq
7.77USD
17 May 2013
7.77USD
17 May 2013
Price Change (% chg)
$0.21 (+2.78%)
$0.21 (+2.78%)
Prev Close
$7.56
$7.56
Open
$7.60
$7.60
Day's High
$7.82
$7.82
Day's Low
$7.56
$7.56
Volume
823,358
823,358
Avg. Vol
1,126,389
1,126,389
52-wk High
$11.36
$11.36
52-wk Low
$5.42
$5.42
| SHAH GAUTAM | Options Exercised: 0 | ||
| Trade Date: | Wednesday, 26 Sep 2012 | Price: | 4.82 |
| Title: | Officer | Shares Held: | 3,125 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 0 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 168 |
| Total Shares Held: | 99,780,224 |
| 3 Mo. Net Change: | 16,633,874 |
| # New Positions: | 28 |
| # Closed Positions: | 16 |
| # Increased Positions: | 101 |
| # Reduced Positions: | 52 |
| # Net Buyers: | 49 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
David Scheer |
60 | 2010 | Chairman of the Board |
Michael Kishbauch |
63 | 2004 | President, Chief Executive Officer, Director |
Mary Fenton |
48 | 2010 | Chief Financial Officer, Senior Vice President |
Gautam Shah |
56 | 2012 | Executive Vice President, Chief Compliance Officer |
Joseph Truitt |
48 | 2012 | Senior Vice President, Chief Commercial Officer |
Milind Deshpande |
55 | 2010 | President - Research and Development, Chief Scientific Officer |
Jason Fisherman |
54 | 2000 | Independent Director |
Gary Frashier |
74 | 2008 | Independent Director |
Kurt Graves |
44 | 2012 | Independent Director |
Dennis Liotta |
2008 | Independent Director | |
Robert Van Nostrand |
55 | 2007 | Independent Director |
Nicole Vitullo |
47 | 2010 | Independent Director |
David Wright |
63 | 2007 | Independent Director |

